Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation | |
---|---|---|
D014135 | Tracheal Stenosis NIH | 1.00 |
D003251 | Constriction, Pathologic NIH | 0.71 |
Name (Synonyms) | Correlation |
---|
Navigate: Correlations HPO
There is one clinical trial.
Define the actual incidence of tracheal stenosis in patients who underwent either prolonged intubation or tracheostomy and to compare incidence, clinical course and outcome between COVID-19 and non-COVID-19 patients.
Description: Observe how many subject in the population at risk will develop tracheal stenosis during follow-up
Measure: Incidence of tracheal stenosis following either prolonged intubation or tracheostomy in COVID-19 patients Time: 8 monthsDescription: Describe symptoms most commonly associated with tracheal stenosis
Measure: Clinical presentation of tracheal stenosis Time: 8 monthsDescription: Analyse the clinical evolution of tracheal stenosis during follow-up
Measure: Clinical course of tracheal stenosis Time: 8 monthsDescription: Collect data on morbidity and mortality of tracheal stenosis
Measure: Outcome of tracheal stenosis Time: 8 monthsDescription: Patient's characteristic (e.g. sex, age, weight and height) will be collected during follow-up to search for any statistically significant association with risk of developing tracheal stenosis or disease-free survival
Measure: Identification of demographic factor with a predictive and prognostic value for tracheal stenosis Time: 8 monthsDescription: Information regarding hospitalisation (e.g. personal history of diabetes, chronic obstructive pulmonary disease, previous prolonged intubation or tracheostomy) will be collected during follow-up to search for any statistically significant association with risk of developing tracheal stenosis or disease-free survival
Measure: Identification of clinical factor with a predictive and prognostic value for tracheal stenosis Time: 8 monthsDescription: Data collected from CT scan performed during follow-up (e.g. distance of stenosis from vocal chords, length and diameter) will be collected during follow-up to search for any statistically significant association with risk of developing tracheal stenosis or disease-free survival
Measure: Identification of radiological factor with a predictive and prognostic value for tracheal stenosis Time: 8 monthsDescription: Results obtained from pulmonary function test (e.g. forced expiratory volume at one second, forced vital capacity and peak expiratory flow rate) will be collected during follow-up to search for any statistically significant association with risk of developing tracheal stenosis or disease-free survival
Measure: Identification of instrumental factor with a predictive and prognostic value for tracheal stenosis Time: 8 monthsDescription: A control-group of patient who underwent either prolonged intubation or tracheostomy without diagnosis of COVID-19 will be used as comparison to search for any difference in primary and secondary outcome
Measure: Compare COVID-19 and non-COVID-19 patients at risk of developing tracheal stenosis Time: 8 monthsAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports